These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7663010)
1. Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease. Nadali G; Vinante F; Rigo A; Tecchio C; Morosato L; Zanolin E; Perona G; Chilosi M; Pizzolo G Int J Clin Lab Res; 1995; 25(2):84-7. PubMed ID: 7663010 [TBL] [Abstract][Full Text] [Related]
2. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma. Abdelrazik N; Fouda M; Zaghloul MH; Abbas D Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393 [TBL] [Abstract][Full Text] [Related]
11. Serum intercellular adhesion molecule-1 in childhood malignancy. Pui CH; Luo X; Evans W; Martin S; Rugg A; Wilimas J; Crist WM; Hudson M Blood; 1993 Aug; 82(3):895-8. PubMed ID: 8101731 [TBL] [Abstract][Full Text] [Related]
12. Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas. Wołowiec D; Frydecka I; Kapelko-Słowik K; Potoczek S; Urbaniak-Kujda D; Kuliczkowski K Med Sci Monit; 2002 May; 8(5):BR175-8. PubMed ID: 12011765 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. Nadali G; Vinante F; Ambrosetti A; Todeschini G; Veneri D; Zanotti R; Meneghini V; Ricetti MM; Benedetti F; Vassanelli A J Clin Oncol; 1994 Apr; 12(4):793-7. PubMed ID: 8151321 [TBL] [Abstract][Full Text] [Related]
14. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma. Harabuchi Y; Kataura A; Imai K Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):634-42. PubMed ID: 8712635 [TBL] [Abstract][Full Text] [Related]
15. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma. Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M Ann Oncol; 1992 Sep; 3 Suppl 4():49-52. PubMed ID: 1333270 [TBL] [Abstract][Full Text] [Related]
16. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Coll-Vinent B; Vilardell C; Font C; Oristrell J; Hernández-Rodríguez J; Yagüe J; Urbano-Márquez A; Grau JM; Cid MC Ann Rheum Dis; 1999 Mar; 58(3):189-92. PubMed ID: 10364919 [TBL] [Abstract][Full Text] [Related]
17. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival. Ballantyne CM; Mainolfi EA; Young JB; Windsor NT; Cocanougher B; Lawrence EC; Pollack MS; Entman ML; Rothlein R J Heart Lung Transplant; 1994; 13(4):597-603. PubMed ID: 7947875 [TBL] [Abstract][Full Text] [Related]
18. Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia. Hatzistilianou M; Athanassiadou F; Agguridaki C; Catriu D Eur J Pediatr; 1997 Jul; 156(7):537-40. PubMed ID: 9243236 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418 [TBL] [Abstract][Full Text] [Related]
20. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]